Starpharma featured on Bulls N' Bears

Sep 22nd, 2023

Starpharma was featured on 3AW's Bulls N' Bears following the announcement about positive DEP® irinotecan clinical results that will be presented at international oncology conference. This was recorded on 20 September 2023. ... Read More

Starpharma featured on ShareCafe

Sep 22nd, 2023

Starpharma was featured on ShareCafe's "Hidden Gems Webinar" following the announcement about positive DEP® irinotecan clinical results that will be presented at international oncology conference. This was recorded on 22 September 2023.  ...   ... Read More

Starpharma interviewed for Fear and Greed podcast

Sep 22nd, 2023

Starpharma was featured in Business News' Fear and Greed following the announcement about positive DEP® irinotecan clinical results that will be presented at international oncology conference.This was recorded on 20 September 2023. ... Read More

Starpharma interviewed for ausbiz

Sep 15th, 2023

Starpharma was featured in ausbiz's Small Caps segment following the announcement about positive DEP® irinotecan clinical results that will be presented at international oncology conference.This was recorded on 14 September 2023. Read More

Commencement of CFO and Company Secretary (ASX Announcement)

Apr 3rd, 2023

Melbourne, Australia; 3 April 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) is pleased to announce that, further to the announcement on 3 March 2023, Mr Justin Cahill commences in the role of Chief Financial Officer (CFO) and Company Secretary today. 

Read More

Starpharma presents at ASX Small and Mid-Cap Conference (ASX Announcement)

Mar 22nd, 2023

Melbourne, Australia; 22 March 2023: Starpharma (ASX: SPL, OTCQX: SPHRY) announces that Starpharma CEO Dr Jackie Fairley will present a brief overview of the Company at the ASX Small and Mid-Cap Conference today at 11:00am AEDT. The Conference showcases selected ASX-listed companies to Australian investors.

Read More